Therefore, advanced knowledge of diabetes pathophysiology and a better understanding of the mechanism of GLP‐1 analogues' action on β‐cell signalling and function will contribute to the development of novel therapeutics in the treatment of T2DM. This evidence concerns the gene GCG and type 2 diabetes mellitus.